Abolis is delivering high-impact innovations in biotechnologies.We provide tailor-made industrial solutions based on micro-organisms.
Abolis Biotechnologies has raised $38.8M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in September 2024.
Abolis Biotechnologies's investors include Clay Capital, Evonik Venture Capital, Liberset, DeepTech & Climate Fonds, ICOS Capital Management.
Abolis Biotechnologies is headquartered in Évry, France.
Abolis is delivering high-impact innovations in biotechnologies.We provide tailor-made industrial solutions based on micro-organisms.
Abolis Biotechnologies is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Abolis Biotechnologies — Funding & Investors." VCBacked, September 12, 2024, https://www.vcbacked.co/company/abolis-biotechnologies. Accessed August 13, 2026.
VCBacked. (2024). Abolis Biotechnologies — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/abolis-biotechnologies
{{cite web |title=Abolis Biotechnologies — Funding & Investors |url=https://www.vcbacked.co/company/abolis-biotechnologies |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated